[
{
  "model": "sites.site",
  "pk": 1,
  "fields": {
    "domain": "example.com",
    "name": "Otsuka Insights"
  }
},
{
  "model": "users.country",
  "pk": 1,
  "fields": {
    "name": "Ukraine",
    "created_at": "2016-12-28T19:38:34.933Z"
  }
},
{
  "model": "users.country",
  "pk": 3,
  "fields": {
    "name": "Spain",
    "created_at": "2016-12-28T20:10:20.497Z"
  }
},
{
  "model": "users.country",
  "pk": 4,
  "fields": {
    "name": "Italy",
    "created_at": "2016-12-28T20:10:26.283Z"
  }
},
{
  "model": "users.country",
  "pk": 5,
  "fields": {
    "name": "France",
    "created_at": "2016-12-28T20:10:33.451Z"
  }
},
{
  "model": "users.user",
  "pk": 1,
  "fields": {
    "password": "pbkdf2_sha256$30000$UWdl3JC7dF3T$P5fhAwI/An8VASMHeqCxbqJSy/ZWyPo1wK+DjKqKi6k=",
    "last_login": "2016-12-30T20:08:55.987Z",
    "is_superuser": true,
    "username": "eugene",
    "first_name": "",
    "last_name": "",
    "email": "eugene.galenko@deepsine.com",
    "is_staff": true,
    "is_active": true,
    "date_joined": "2016-12-26T15:54:50Z",
    "name": "",
    "country": 3,
    "groups": [],
    "user_permissions": []
  }
},
{
  "model": "users.user",
  "pk": 2,
  "fields": {
    "password": "pbkdf2_sha256$30000$XtLsu1GCbl16$T3nOncrmMAWLTym66d6ywY15QWppZwoO9jxZ/exTCwo=",
    "last_login": "2016-12-26T19:18:12.343Z",
    "is_superuser": false,
    "username": "test",
    "first_name": "Test",
    "last_name": "Test",
    "email": "test@deepsine.com",
    "is_staff": false,
    "is_active": true,
    "date_joined": "2016-12-26T15:57:47Z",
    "name": "Test",
    "country": null,
    "groups": [],
    "user_permissions": []
  }
},
{
  "model": "survey.region",
  "pk": 1,
  "fields": {
    "name": "East",
    "country": 3,
    "created_at": "2016-12-28T20:10:55.914Z"
  }
},
{
  "model": "survey.region",
  "pk": 2,
  "fields": {
    "name": "West",
    "country": 3,
    "created_at": "2016-12-28T20:11:01.434Z"
  }
},
{
  "model": "survey.organization",
  "pk": 1,
  "fields": {
    "name": "Drug Abuse Specialised Mental Health Centre",
    "created_at": "2016-12-28T20:08:48.538Z"
  }
},
{
  "model": "survey.organization",
  "pk": 2,
  "fields": {
    "name": "Mental Health Centres",
    "created_at": "2016-12-28T20:08:55.070Z"
  }
},
{
  "model": "survey.organization",
  "pk": 3,
  "fields": {
    "name": "Hospital",
    "created_at": "2016-12-28T20:09:04.217Z"
  }
},
{
  "model": "survey.question",
  "pk": 1,
  "fields": {
    "type": "type_two_dependend_fields",
    "field": 1,
    "text": "How many of your Patients with SCZ have Substance abuse?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:25:12.476Z"
  }
},
{
  "model": "survey.question",
  "pk": 2,
  "fields": {
    "type": "type_yes_no",
    "field": null,
    "text": "Do you treat patients with SCZ and Substance abuse differently to other Patients with SCZ?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:28:23.239Z"
  }
},
{
  "model": "survey.question",
  "pk": 3,
  "fields": {
    "type": "type_multiselect_with_other",
    "field": null,
    "text": "Which antipsychotic do you use for the treatment of SCZ in Patients with SCZ and Substance\r\nabuse in maintenance setting?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:29:21.105Z"
  }
},
{
  "model": "survey.question",
  "pk": 4,
  "fields": {
    "type": "type_multiselect_with_other",
    "field": null,
    "text": "What is your rationale to chose one treatment over another?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:29:37.680Z"
  }
},
{
  "model": "survey.question",
  "pk": 5,
  "fields": {
    "type": "type_yes_no",
    "field": null,
    "text": "Do you have experience with ARI for the treatment of SCZ in patients with SCZ and substance\r\nabuse?",
    "depends_of": 1,
    "dependency_type": 2,
    "script": "//alert('test');",
    "created_at": "2016-12-28T20:30:42.038Z"
  }
},
{
  "model": "survey.question",
  "pk": 6,
  "fields": {
    "type": "type_multiselect_ordered",
    "field": null,
    "text": "Why would you choose ARI over another antipsychotic?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:31:02.240Z"
  }
},
{
  "model": "survey.question",
  "pk": 7,
  "fields": {
    "type": "type_multiselect_with_other",
    "field": null,
    "text": "How is the patient group \u201cPatients with SCZ and Concomitant Substance\r\nAbuse\u201d defined?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:31:36.750Z"
  }
},
{
  "model": "survey.question",
  "pk": 8,
  "fields": {
    "type": "type_dependeend_question",
    "field": 2,
    "text": "Out of the last 10 patients with SCZ, how many have Substance abuse?",
    "depends_of": 1,
    "dependency_type": 1,
    "script": "",
    "created_at": "2016-12-28T21:31:27.964Z"
  }
},
{
  "model": "survey.option",
  "pk": 1,
  "fields": {
    "question": 3,
    "value": "Ari-oral",
    "ordering": 0,
    "created_at": "2016-12-28T21:32:56.080Z"
  }
},
{
  "model": "survey.option",
  "pk": 2,
  "fields": {
    "question": 3,
    "value": "Ari-LAI",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:05.286Z"
  }
},
{
  "model": "survey.option",
  "pk": 3,
  "fields": {
    "question": 3,
    "value": "Resperidol-oral",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:18.702Z"
  }
},
{
  "model": "survey.option",
  "pk": 4,
  "fields": {
    "question": 3,
    "value": "Resperidol-LAI",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:26.478Z"
  }
},
{
  "model": "survey.option",
  "pk": 5,
  "fields": {
    "question": 3,
    "value": "Quetapin-oral",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:34.413Z"
  }
},
{
  "model": "survey.option",
  "pk": 6,
  "fields": {
    "question": 3,
    "value": "Aloperidol-oral",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:42.062Z"
  }
},
{
  "model": "survey.option",
  "pk": 7,
  "fields": {
    "question": 3,
    "value": "Aloperidol-LAI",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:56.801Z"
  }
},
{
  "model": "survey.option",
  "pk": 8,
  "fields": {
    "question": 4,
    "value": "Age",
    "ordering": 0,
    "created_at": "2016-12-28T21:35:39.053Z"
  }
},
{
  "model": "survey.option",
  "pk": 9,
  "fields": {
    "question": 4,
    "value": "Mechanism of Action",
    "ordering": 0,
    "created_at": "2016-12-28T21:35:56.827Z"
  }
},
{
  "model": "survey.option",
  "pk": 10,
  "fields": {
    "question": 4,
    "value": "Preference of the patients",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:05.528Z"
  }
},
{
  "model": "survey.option",
  "pk": 11,
  "fields": {
    "question": 4,
    "value": "Efficacy profile",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:18.150Z"
  }
},
{
  "model": "survey.option",
  "pk": 12,
  "fields": {
    "question": 4,
    "value": "Tolerability profile",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:27.935Z"
  }
},
{
  "model": "survey.option",
  "pk": 13,
  "fields": {
    "question": 4,
    "value": "Health care system specific",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:36.514Z"
  }
},
{
  "model": "survey.option",
  "pk": 14,
  "fields": {
    "question": 4,
    "value": "Pre-dominancy of Symptoms",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:46.550Z"
  }
},
{
  "model": "survey.option",
  "pk": 15,
  "fields": {
    "question": 6,
    "value": "Age",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:01.682Z"
  }
},
{
  "model": "survey.option",
  "pk": 16,
  "fields": {
    "question": 6,
    "value": "Mechanism of Action",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:16.652Z"
  }
},
{
  "model": "survey.option",
  "pk": 17,
  "fields": {
    "question": 6,
    "value": "Preference of the patients",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:24.884Z"
  }
},
{
  "model": "survey.option",
  "pk": 18,
  "fields": {
    "question": 6,
    "value": "Efficacy profile",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:32.141Z"
  }
},
{
  "model": "survey.option",
  "pk": 19,
  "fields": {
    "question": 6,
    "value": "Tolerability profile",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:39.970Z"
  }
},
{
  "model": "survey.option",
  "pk": 20,
  "fields": {
    "question": 6,
    "value": "Health care system specific",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:47.202Z"
  }
},
{
  "model": "survey.option",
  "pk": 21,
  "fields": {
    "question": 6,
    "value": "Pre-dominancy of Symptoms",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:57.975Z"
  }
},
{
  "model": "survey.option",
  "pk": 22,
  "fields": {
    "question": 7,
    "value": "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)",
    "ordering": 0,
    "created_at": "2016-12-28T21:41:50.553Z"
  }
},
{
  "model": "survey.option",
  "pk": 23,
  "fields": {
    "question": 7,
    "value": "Substance abuse including Drugs and Alcohol",
    "ordering": 0,
    "created_at": "2016-12-28T21:42:48.730Z"
  }
},
{
  "model": "survey.survey",
  "pk": 1,
  "fields": {
    "name": "Test",
    "active": true,
    "created_at": "2016-12-28T22:01:34.162Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 1,
  "fields": {
    "survey": 1,
    "question": 1,
    "ordering": 1,
    "created_at": "2016-12-28T22:01:57.556Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 2,
  "fields": {
    "survey": 1,
    "question": 2,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:06.659Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 3,
  "fields": {
    "survey": 1,
    "question": 3,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:11.828Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 4,
  "fields": {
    "survey": 1,
    "question": 4,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:24.077Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 5,
  "fields": {
    "survey": 1,
    "question": 5,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:32.121Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 6,
  "fields": {
    "survey": 1,
    "question": 6,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:37.154Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 7,
  "fields": {
    "survey": 1,
    "question": 7,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:42.379Z"
  }
},
{
  "model": "survey.hcpcategory",
  "pk": 1,
  "fields": {
    "name": "KOL",
    "created_at": "2016-12-29T23:28:37.942Z"
  }
},
{
  "model": "survey.hcpcategory",
  "pk": 2,
  "fields": {
    "name": "Rising star",
    "created_at": "2016-12-29T23:28:44.255Z"
  }
},
{
  "model": "survey.hcpcategory",
  "pk": 3,
  "fields": {
    "name": "Other HCP",
    "created_at": "2016-12-29T23:28:49.367Z"
  }
},
{
  "model": "survey.answer",
  "pk": 1,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2016-12-30T12:52:47.544Z"
  }
},
{
  "model": "survey.answer",
  "pk": 2,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[1][additional]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "mTe2fHFIi0WkQcf6fdeX6xQRmI9ObjnrHzfgsUYDZ8ahPpMDYQ3pB9Lvu9c35udr"
      ],
      "data[4][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[3][other]": [
        ""
      ],
      "data[1][main]": [
        ""
      ],
      "data[6][other]": [
        ""
      ]
    },
    "created_at": "2016-12-30T15:57:48.514Z"
  }
},
{
  "model": "survey.answer",
  "pk": 3,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2016-12-31T02:26:07.906Z"
  }
},
{
  "model": "survey.answer",
  "pk": 4,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 2,
    "organization": 3,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[1][additional]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "SQatEcIRWq4pUajcu7RBy8xPaJ82EYGadwbHRp1MDyimTnQJdKG33Kstiabhy9wa"
      ],
      "data[4][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][main]": [
        ""
      ],
      "data[3][other]": [
        ""
      ],
      "data[6][]": [
        "Preference of the patients",
        "Health care system specific",
        "Tolerability profile",
        "Pre-dominancy of Symptoms"
      ]
    },
    "created_at": "2016-12-31T10:34:21.766Z"
  }
},
{
  "model": "survey.answer",
  "pk": 5,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[1][additional]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[4][]": [
        "Preference of the patients",
        "Tolerability profile"
      ],
      "data[7][]": [
        "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)"
      ],
      "data[6][]": [
        "Mechanism of Action",
        "Health care system specific",
        "Tolerability profile"
      ],
      "csrfmiddlewaretoken": [
        "B6kact0CfQemdZ5HK4K9PbBgh7mJ2FVWWMlopGjxWYsjccCetHzBkNwUpypYWQLW"
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][main]": [
        ""
      ],
      "data[3][other]": [
        ""
      ],
      "data[3][]": [
        "Quetapin-oral",
        "Aloperidol-LAI"
      ],
      "data[5]": [
        "No"
      ]
    },
    "created_at": "2016-12-31T10:43:12.823Z"
  }
},
{
  "model": "survey.answer",
  "pk": 6,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 2,
    "survey": 1,
    "data": {
      "data[1][additional]": [
        "4"
      ],
      "data[7][other]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[4][]": [
        "Age",
        "Efficacy profile",
        "Health care system specific"
      ],
      "data[7][]": [
        "Substance abuse including Drugs and Alcohol"
      ],
      "data[6][]": [
        "Age",
        "Health care system specific",
        "Preference of the patients"
      ],
      "csrfmiddlewaretoken": [
        "FFrSoYmETi5GjLzEJEiozIBDqQ2qLloD0ls6BbFzAqjDiY6bsh7Q4kwhyh5FFweD"
      ],
      "data[2]": [
        "Yes"
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][main]": [
        "22"
      ],
      "data[3][other]": [
        ""
      ],
      "data[3][]": [
        "Ari-oral",
        "Resperidol-oral",
        "Quetapin-oral"
      ]
    },
    "created_at": "2016-12-31T10:46:56.391Z"
  }
},
{
  "model": "survey.answer",
  "pk": 7,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[6][]": [
        "Health care system specific"
      ],
      "csrfmiddlewaretoken": [
        "QPNLuOR9ehEhnEDVl6IV6jOViNGqh1Q8bvOZH1a4VpSemRas4JxnBVJzqeJFbcG8"
      ],
      "data[4][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][main]": [
        "33"
      ],
      "data[1][additional]": [
        ""
      ],
      "data[3][other]": [
        ""
      ],
      "data[3][]": [
        "Quetapin-oral",
        "Aloperidol-oral"
      ]
    },
    "created_at": "2017-01-02T10:52:51.382Z"
  }
},
{
  "model": "account.emailaddress",
  "pk": 1,
  "fields": {
    "user": 2,
    "email": "test@deepsine.com",
    "verified": false,
    "primary": false
  }
}
]
